List of Excipients in API ciclopirox
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ciclopirox
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | CICLOPIROX | ciclopirox | 0168-0522 | DISODIUM LAURETH SULFOSUCCINATE | |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | CICLOPIROX | ciclopirox | 0168-0522 | LAURETH-2 | |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | CICLOPIROX | ciclopirox | 0168-0522 | SODIUM CHLORIDE | |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | CICLOPIROX | ciclopirox | 0168-0522 | SODIUM LAURETH-3 SULFATE | |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | CICLOPIROX | ciclopirox | 0168-0522 | WATER | |
| Bausch Health US LLC | PENLAC | ciclopirox | 0187-5180 | BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ciclopirox
Detailed excipient profiles for ciclopirox
Excipient focus: ((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE
ciclopirox drug variants containing ((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | ciclopirox | 0713-0317 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing ((2S,3S,5S)-2-(2-(2,6-DIMETHYLPHENOXY)ACETAMIDO)-5-((S)-3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANAMIDO)-1,6-DIPHENYLHEXAN-3-YL) 3-METHYL-2-(2-OXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BUTANOATE
Excipient focus: BENZYL ALCOHOL
ciclopirox drug variants containing BENZYL ALCOHOL
ciclopirox drug variants not containing BENZYL ALCOHOL
Excipient focus: BUTYL ESTER OF METHYL VINYL ETHER-MALEIC ANHYDRIDE COPOLYMER
ciclopirox drug variants containing BUTYL ESTER OF METHYL VINYL ETHER-MALEIC ANHYDRIDE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | ciclopirox | 54868-6064 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing BUTYL ESTER OF METHYL VINYL ETHER-MALEIC ANHYDRIDE COPOLYMER
Excipient focus: BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER
ciclopirox drug variants containing BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER
ciclopirox drug variants not containing BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
ciclopirox drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | ciclopirox | 0168-0407 |
| Padagis US LLC | ciclopirox | 0574-2061 |
| Alvogen Inc | ciclopirox | 47781-530 |
| Bryant Ranch Prepack | ciclopirox | 63629-8620 |
| Bryant Ranch Prepack | ciclopirox | 63629-8621 |
| Bryant Ranch Prepack | ciclopirox | 63629-8622 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Excipient focus: CETYL ALCOHOL
ciclopirox drug variants containing CETYL ALCOHOL
ciclopirox drug variants not containing CETYL ALCOHOL
Excipient focus: COCAMIDE
ciclopirox drug variants containing COCAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Leading Pharma LLC | ciclopirox olamine | 69315-309 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing COCAMIDE
Excipient focus: COCO DIETHANOLAMIDE
ciclopirox drug variants containing COCO DIETHANOLAMIDE
ciclopirox drug variants not containing COCO DIETHANOLAMIDE
Excipient focus: DISODIUM LAURETH SULFOSUCCINATE
ciclopirox drug variants containing DISODIUM LAURETH SULFOSUCCINATE
ciclopirox drug variants not containing DISODIUM LAURETH SULFOSUCCINATE
Excipient focus: DOCUSATE SODIUM
ciclopirox drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | ciclopirox | 0168-0407 |
| Padagis US LLC | ciclopirox | 0574-2061 |
| Alvogen Inc | ciclopirox | 47781-530 |
| Bryant Ranch Prepack | ciclopirox | 63629-8620 |
| Bryant Ranch Prepack | ciclopirox | 63629-8621 |
| Bryant Ranch Prepack | ciclopirox | 63629-8622 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing DOCUSATE SODIUM
Excipient focus: ETHYL ACETATE
ciclopirox drug variants containing ETHYL ACETATE
ciclopirox drug variants not containing ETHYL ACETATE
Excipient focus: ISOPROPYL ACETATE
ciclopirox drug variants containing ISOPROPYL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | ciclopirox | 0713-0317 |
| Taro Pharmaceuticals USA Inc | ciclopirox | 51672-5302 |
| NuCare PharmaceuticalsInc | ciclopirox | 68071-4977 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing ISOPROPYL ACETATE
Excipient focus: ISOPROPYL ALCOHOL
ciclopirox drug variants containing ISOPROPYL ALCOHOL
ciclopirox drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTIC ACID
ciclopirox drug variants containing LACTIC ACID
ciclopirox drug variants not containing LACTIC ACID
Excipient focus: LAURETH-2
ciclopirox drug variants containing LAURETH-2
ciclopirox drug variants not containing LAURETH-2
Excipient focus: LIGHT MINERAL OIL
ciclopirox drug variants containing LIGHT MINERAL OIL
ciclopirox drug variants not containing LIGHT MINERAL OIL
Excipient focus: MALEIC ACID
ciclopirox drug variants containing MALEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | ciclopirox | 21695-475 |
| Akorn | ciclopirox | 50383-419 |
| Preferred Pharmaceuticals Inc | ciclopirox | 68788-7138 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing MALEIC ACID
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
ciclopirox drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | ciclopirox | 68462-455 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: MINERAL OIL
ciclopirox drug variants containing MINERAL OIL
ciclopirox drug variants not containing MINERAL OIL
Excipient focus: MYRISTYL ALCOHOL
ciclopirox drug variants containing MYRISTYL ALCOHOL
ciclopirox drug variants not containing MYRISTYL ALCOHOL
Excipient focus: OCTYLDODECANOL
ciclopirox drug variants containing OCTYLDODECANOL
ciclopirox drug variants not containing OCTYLDODECANOL
Excipient focus: PEG/PPG-18/18 DIMETHICONE
ciclopirox drug variants containing PEG/PPG-18/18 DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | ciclopirox | 0168-0407 |
| Padagis US LLC | ciclopirox | 0574-2061 |
| Alvogen Inc | ciclopirox | 47781-530 |
| Bryant Ranch Prepack | ciclopirox | 63629-8620 |
| Bryant Ranch Prepack | ciclopirox | 63629-8621 |
| Bryant Ranch Prepack | ciclopirox | 63629-8622 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing PEG/PPG-18/18 DIMETHICONE
Excipient focus: POLYSORBATE 60
ciclopirox drug variants containing POLYSORBATE 60
ciclopirox drug variants not containing POLYSORBATE 60
Excipient focus: SODIUM CHLORIDE
ciclopirox drug variants containing SODIUM CHLORIDE
ciclopirox drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
ciclopirox drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | ciclopirox | 0168-0407 |
| Padagis US LLC | ciclopirox | 0574-2061 |
| Alvogen Inc | ciclopirox | 47781-530 |
| Bryant Ranch Prepack | ciclopirox | 63629-8620 |
| Bryant Ranch Prepack | ciclopirox | 63629-8621 |
| Bryant Ranch Prepack | ciclopirox | 63629-8622 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURETH SULFATE
ciclopirox drug variants containing SODIUM LAURETH SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals Inc | ciclopirox | 61360-1351 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing SODIUM LAURETH SULFATE
Excipient focus: SODIUM LAURETH-2 SULFATE
ciclopirox drug variants containing SODIUM LAURETH-2 SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | ciclopirox | 0591-2159 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing SODIUM LAURETH-2 SULFATE
Excipient focus: SODIUM LAURETH-3 SULFATE
ciclopirox drug variants containing SODIUM LAURETH-3 SULFATE
ciclopirox drug variants not containing SODIUM LAURETH-3 SULFATE
Excipient focus: SODIUM LAURYL SULFATE
ciclopirox drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | ciclopirox | 68462-455 |
| >Company | >Ingredient | >NDC |
ciclopirox drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SORBITAN MONOSTEARATE
ciclopirox drug variants containing SORBITAN MONOSTEARATE
ciclopirox drug variants not containing SORBITAN MONOSTEARATE
Excipient focus: STEARYL ALCOHOL
ciclopirox drug variants containing STEARYL ALCOHOL
ciclopirox drug variants not containing STEARYL ALCOHOL
Excipient focus: WATER
ciclopirox drug variants containing WATER
ciclopirox drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
